CapitalWatch

New Horizon Health was China’s first cancer-screening device company to go public, and was once the envy of the industry as its revenue surged more than 20 times in the three years through 2023 and its gross margin jumped from 52% to 90%.

FAST NEWS: New Horizon Health CFO, auditor resign

The Latest: Cancer-screening device maker New Horizon Health Ltd. (6606.HK) announced Monday that Deloitte has resigned as its auditor, effective Sept. 9. Separately, the company said its CFO Gao Yu also announced…
6606.HK

Recent Articles

RELATED ARTICLES

  1. BRIEF: New Horizon Health announces chairman’s departure
    6606.HK
  2. Horizon’s lead grows in smart driving race with new product rollouts
    9660.HK
  3. Cash-strapped Mirxes looks for lifeline in blood-based cancer detection
  4. Horizon Robotics debuts strongly, fueled by autonomous driving boom
    9660.HK
  5. Everest Medicines drives growth with AI-powered mRNA pipeline
    1952.HK
  6. BRIEF: Dida changes auditor from Deloitte to local Hong Kong company
    2559.HK
  7. Auditor drama casts unflattering light on Lufax at already-difficult time
    6623.HK LU.US
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva